Doxycycline inhibits the cancer stem cell phenotype and epithelial-to-mesenchymal transition in breast cancer
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Doxycycline inhibits the cancer stem cell phenotype and epithelial-to-mesenchymal transition in breast cancer
Authors
Keywords
-
Journal
CELL CYCLE
Volume 16, Issue 8, Pages 737-745
Publisher
Informa UK Limited
Online
2016-10-18
DOI
10.1080/15384101.2016.1241929
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2016
- (2016) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- New Findings on Breast Cancer Stem Cells: A Review
- (2015) Azam Bozorgi et al. Journal of Breast Cancer
- Melanoma cells influence the differentiation pattern of human epidermal keratinocytes
- (2015) Ondřej Kodet et al. Molecular Cancer
- Autophagy Supports Breast Cancer Stem Cell Maintenance by Regulating IL6 Secretion
- (2015) Paola Maycotte et al. MOLECULAR CANCER RESEARCH
- Inhibition of COP9-signalosome (CSN) deneddylating activity and tumor growth of diffuse large B-cell lymphomas by doxycycline
- (2015) Mary Pulvino et al. Oncotarget
- Doxycycline down-regulates DNA-PK and radiosensitizes tumor initiating cells: Implications for more effective radiation therapy
- (2015) Rebecca Lamb et al. Oncotarget
- Antibiotics that target mitochondria effectively eradicate cancer stem cells, across multiple tumor types: Treating cancer like an infectious disease
- (2015) Rebecca Lamb et al. Oncotarget
- TALEN-mediated Nanog disruption results in less invasiveness, more chemosensitivity and reversal of EMT in Hela cells
- (2015) Yan Ding et al. Oncotarget
- Mitochondria as new therapeutic targets for eradicating cancer stem cells: Quantitative proteomics and functional validation via MCT1/2 inhibition
- (2015) Rebecca Lamb et al. Oncotarget
- Oct-4 and nanog promote the epithelial-mesenchymal transition of breast cancer stem cells and are associated with poor prognosis in breast cancer patients
- (2015) Dan Wang et al. Oncotarget
- Metabolic differences in breast cancer stem cells and differentiated progeny
- (2014) Erina Vlashi et al. BREAST CANCER RESEARCH AND TREATMENT
- Doxycycline as an Inhibitor of the Epithelial-to-Mesenchymal Transition and Vasculogenic Mimicry in Hepatocellular Carcinoma
- (2014) J. Meng et al. MOLECULAR CANCER THERAPEUTICS
- NDRG2 Controls COX-2/PGE2-Mediated Breast Cancer Cell Migration and Invasion
- (2014) Myung-Jin Kim et al. MOLECULES AND CELLS
- Targeting Unique Metabolic Properties of Breast Tumor Initiating Cells
- (2014) Weiguo Feng et al. STEM CELLS
- Breast cancer stem cells rely on fermentative glycolysis and are sensitive to 2-deoxyglucose treatment
- (2014) D Ciavardelli et al. Cell Death & Disease
- Breast Cancer Stem Cells Transition between Epithelial and Mesenchymal States Reflective of their Normal Counterparts
- (2014) Suling Liu et al. Stem Cell Reports
- Autophagy in stem cells
- (2013) Jun-Lin Guan et al. Autophagy
- Targeted elimination of breast cancer cells with low proteasome activity is sufficient for tumor regression
- (2013) Erina Vlashi et al. BREAST CANCER RESEARCH AND TREATMENT
- Minocycline: far beyond an antibiotic
- (2013) N Garrido-Mesa et al. BRITISH JOURNAL OF PHARMACOLOGY
- The Residual Tumor Autophagy Marker LC3B Serves as a Prognostic Marker in Local Advanced Breast Cancer after Neoadjuvant Chemotherapy
- (2013) S. Chen et al. CLINICAL CANCER RESEARCH
- The roles of BECN1 and autophagy in cancer are context dependent
- (2012) Chang Gong et al. Autophagy
- Cancer stem cells and drug resistance: the potential of nanomedicine
- (2012) Serguei Vinogradov et al. Nanomedicine
- Beclin 1 and autophagy are required for the tumorigenicity of breast cancer stem-like/progenitor cells
- (2012) C Gong et al. ONCOGENE
- Radiation-Induced Reprogramming of Breast Cancer Cells
- (2012) Chann Lagadec et al. STEM CELLS
- Matrix metalloproteinase inhibition therapy for vascular diseases
- (2012) Andrew C. Newby VASCULAR PHARMACOLOGY
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Autophagy positively regulates the CD44+CD24-/lowbreast cancer stem-like phenotype
- (2011) Sílvia Cufí et al. CELL CYCLE
- Punctate LC3B Expression Is a Common Feature of Solid Tumors and Associated with Proliferation, Metastasis, and Poor Outcome
- (2011) R. Lazova et al. CLINICAL CANCER RESEARCH
- The non-antibiotic properties of tetracyclines: Clinical potential in ophthalmic disease
- (2011) Thomas J. Federici PHARMACOLOGICAL RESEARCH
- Metabolic state of glioma stem cells and nontumorigenic cells
- (2011) E. Vlashi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Epithelial and Mesenchymal Subpopulations Within Normal Basal Breast Cell Lines Exhibit Distinct Stem Cell/Progenitor Properties
- (2011) David Sarrio et al. STEM CELLS
- Tetracycline compounds with non-antimicrobial organ protective properties: Possible mechanisms of action
- (2010) Michael O. Griffin et al. PHARMACOLOGICAL RESEARCH
- Cooperation of Cancer Stem Cell Properties and Epithelial-Mesenchymal Transition in the Establishment of Breast Cancer Metastasis
- (2010) Tetsu Hayashida et al. Journal of Oncology
- Radiation responses of cancer stem cells
- (2009) Erina Vlashi et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Autophagy fights disease through cellular self-digestion
- (2008) Noboru Mizushima et al. NATURE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now